http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9649392-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1af8df51ce24ca931ae718fb747f6aa0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M36-14 |
| filingDate | 2014-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9354847b8e552d5d39ad19cbe0bfa705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae9860736583b6ca6aae66cfe067ad8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64f8948335c408689f06e6e6fee36275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6611598e5d202717fc98a86df908ef7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115f52858615b48ec88b45f8fd7750a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44774bb13a14d99f173660760cb1e675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf2200209ef8fd7121a6df776209baf |
| publicationDate | 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-9649392-B2 |
| titleOfInvention | Central nervous system labelling composition for intranasal administration and labelling method and screening method using central nervous system labelling composition for intranasal administration |
| abstract | There is provided a central nervous system labelling composition for intranasal administration for the purpose of labelling the central nervous system from the olfactory epithelium by way of the olfactory bulb and by means of intranasal administration. Additionally, there is provided a method of non-invasively labelling the central nervous system by way of an administration route that entails little transferability to the entire body. Furthermore, there is provided a screening method using a central nervous system labelling composition for intranasal administration. A central nervous system labelling composition for intranasal administration is characterized by labelling the central nervous system from the olfactory epithelium by way of the olfactory bulb and by means of intranasal administration and by containing at least one compound expressed either by the general formula (1) or the general formula (2) shown below as effective component: |
| priorityDate | 2009-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.